Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
IBUPROFENO CINFA 40 MG/ML SUSPENSION ORAL EFG
Suspension
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- IBUPROFENO — 40 mg
- Pharmaceutical form Home Med Cabinet grouping
- Suspension
- Availability in Spain
- 2 of 4 packs marketed
Packs
IBUPROFENO CINFA 40 MG/ML SUSPENSION ORAL EFG , frasco de 100 ml de suspensión
100 ml
National code
Not marketed699127Strength of this pack 40 mg
IBUPROFENO CINFA 40 MG/ML SUSPENSION ORAL EFG , frasco de 200 ml de suspensión
200 ml
National code
Marketed699128Strength of this pack 40 mg
IBUPROFENO CINFA 40 MG/ML SUSPENSION ORAL EFG , frasco de 30 ml de suspensión
30 ml
National code
Not marketed699129Strength of this pack 40 mg
IBUPROFENO CINFA 40 MG/ML SUSPENSION ORAL EFG , frasco de 150 ml de suspensión
150 ml
National code
Marketed699130Strength of this pack 40 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 77857Official data
- Marketing authorisation holder
- LABORATORIOS CINFA S.A.Official data
- Authorised
- Aug 19, 2013Official data
- Authority form code
- 6Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.